Creating a better, safer world.
Hypovolemic shock. That’s what happens when people lose too much blood, resulting in blood plasma being too low. If left untreated, hypovolemic shock can lead to death. But what if there was an easy and clean way to prevent this? A way that would minimize first responders’ contact with blood-borne diseases while still reducing blood flow and the chance of infection? Meet BC3 Technologies. BC3T has developed a Chitosan-based aerosol that has powerful anti- hemorrhagic and anti-microbial properties.
BC3 Technologies was founded by Wayne, the company’s CEO. He has a finance background and an aerosol business that does contract packaging with big name companies. Wayne describes his work as helping make everyone else’s dreams a reality. For example, he helped Aeronics, a company in Quake’s last cohort, manufacture its product. This piqued his curiosity.
Wayne had the ability and knowledge to make what he wanted, and wound dressings had always been an interest of his. He wanted to do something to make a difference and save lives. After experiencing police brutality and random acts of violence in Baltimore, Wayne wanted to help mediate that to some extent. Thus the idea of BC3T was born.
Lee is BC3 Technologies’ COO, and is actually Wayne’s brother. The CFO of BC3T is Karen. Karen is the Controller for Wayne’s aerosol packaging company, and after knowing and doing business with Wayne for years, was a good fit for the company.
Wayne knew the material he wanted to use: Chitosan. Chitosan is made of bleached and sanitized crustacean shells, and has good hemostatic properties. Wayne wanted to amplify these. Being based in Maryland was also great for the company — Maryland is the land of crab. From here, he found experts in the Chitosan space, Dr. Rivelino Montenegro and Dr. Thomas Frier.
Dr. Montenegro and Dr. Frier already had a company that made Chitosan-based products, and so they helped develop BC3T’s product. In order to test the new product, the team sent it to Dr. Kiribati, the Head of the Army Surgical Unit in Houston. Dr. Kiribati loved it and wrote a great letter of recommendation. Currently, BC3T is awaiting FDA approval.
For a while, Wayne shelved BC3T. However, he soon realized he wanted to make his dream his reality. The company is currently preparing to roll out its chitosan spray. When asked where he sees BC3T in one year, Wayne said that he sees the company producing and selling its product both domestically and internationally. He sees BC3T’s chitosan spray saving lives, by selling the product to different branches of the military, first responders, and people in other countries. He emphasizes that you can’t put a dollar amount on someone’s life.
BC3T is excited to be in Quake’s accelerator. Wayne says he has certain skill set, in that he can tell you how to make things. He is a self-described “geek” that likes to tinker with things. But he wanted some guidance as to where to go from there. Through Quake, Wayne and the BC3T team is excited to learn, as this will push them to open their eyes up more and absorb as much as they can. They are also look looking to grow as a company and a team and meet new people. Quake is happy to invest in BC3T because not only does the company have the potential to grow, but it also saves lives.
